CONTRASTING EFFECTS OF PROPIONATE AND PROPIONYL-L-CARNITINE ON ENERGY-LINKED PROCESSES IN ISCHEMIC HEARTS

被引:22
作者
DILISA, F [1 ]
MENABO, R [1 ]
BARBATO, R [1 ]
SILIPRANDI, N [1 ]
机构
[1] CNR,CTR STUDIO FISIOL MITOCONDRIALE,I-35121 PADUA,ITALY
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 267卷 / 02期
关键词
ISCHEMIA; MITOCHONDRIA; L-CARNITINE; COENZYME A;
D O I
10.1152/ajpheart.1994.267.2.H455
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Propionyl-L-carnitine, unlike L-carnitine, is known to improve myocardial function and metabolism altered during the course of ischemia-reperfusion. In this study, the effect of propionyl-L-carnitine has been compared with that of propionate and carnitine on the performance of rat hearts perfused with a glucose-containing medium either under normoxia, ischemia, or postischemic reperfusion. In the postischemic phase, contractile parameters were partially restored both in the control and in the propionate plus carnitine-treated hearts, were markedly impaired by propionate, and were fully recovered by propionyl-L-carnitine. In addition, propionyl-L-carnitine, but not propionate, reduced the functional decay of mitochondria prepared from the ischemic hearts. Even in normoxic conditions propionate, unlike propionyl-L-carnitine, caused a drastic reduction of free CoA and L-carnitine. The concomitant increase in lactate production and decrease in ATP content might be explained by the inhibition of pyruvate dehydrogenase caused by the accumulation of propionyl-CoA. Indeed, when pyruvate was the only oxidizable substrate, propionate induced a gradual decrease in developed pressure, which was largely prevented by L-carnitine. The protective effect of propionyl-L-carnitine may be a consequence of the anaplerotic utilization of propionate in the presence of an optimal amount of ATP and free L-carnitine.
引用
收藏
页码:H455 / H461
页数:7
相关论文
共 28 条
  • [1] EFFECTS OF PROPIONATE ON MECHANICAL AND METABOLIC PERFORMANCE IN AEROBIC RAT HEARTS
    BOLUKOGLU, H
    NELLIS, SH
    LIEDTKE, AJ
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 : 37 - 44
  • [2] SUPERIORITY OF L-PROPIONYLCARNITINE VS L-CARNITINE IN IMPROVING WALKING CAPACITY IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE - AN ACUTE, INTRAVENOUS, DOUBLE-BLIND, CROSS-OVER STUDY
    BREVETTI, G
    PERNA, S
    SABBA, C
    ROSSINI, A
    DIUCCIO, VS
    BERARDI, E
    GODI, L
    [J]. EUROPEAN HEART JOURNAL, 1992, 13 (02) : 251 - 255
  • [3] MECHANISM OF ANTIKETOGENIC ACTION OF PROPIONATE AND SUCCINATE IN ISOLATED RAT-LIVER MITOCHONDRIA
    CIMAN, M
    ROSSI, CR
    SILIPRAN.N
    [J]. FEBS LETTERS, 1972, 22 (01) : 8 - &
  • [4] DEGROOT MJM, 1992, MOL CELL BIOCHEM, V118, P1
  • [5] DILISA F, 1993, CARDIOVASC RES, V27, P1840
  • [6] DILISA F, 1989, MOL CELL BIOCHEM, V88, P169
  • [7] DILISA F, 1992, CIRCULATION, V86, P35
  • [8] PROLONGED PROPIONYL-L-CARNITINE PRETREATMENT OF RABBIT - BIOCHEMICAL, HEMODYNAMIC AND ELECTROPHYSIOLOGICAL EFFECTS ON MYOCARDIUM
    FERRARI, R
    DILISA, F
    DEJONG, JW
    CECONI, C
    PASINI, E
    BARBATO, R
    MENABO, R
    BARBIERI, M
    CERBAI, E
    MUGELLI, A
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 (03) : 219 - 232
  • [9] FERRARI R, 1989, MOL CELL BIOCHEM, V88, P161
  • [10] Gutmann I., 1974, METHOD ENZYMAT AN, P1464